CA2668608A1 - Methods for using aldhbr cells to supplement stem cell transplantation - Google Patents

Methods for using aldhbr cells to supplement stem cell transplantation Download PDF

Info

Publication number
CA2668608A1
CA2668608A1 CA002668608A CA2668608A CA2668608A1 CA 2668608 A1 CA2668608 A1 CA 2668608A1 CA 002668608 A CA002668608 A CA 002668608A CA 2668608 A CA2668608 A CA 2668608A CA 2668608 A1 CA2668608 A1 CA 2668608A1
Authority
CA
Canada
Prior art keywords
cells
population
subject
cell
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002668608A
Other languages
English (en)
French (fr)
Inventor
Joanne Kurtzberg
N. Rebecca Haley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aldagen Inc
Duke University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2668608A1 publication Critical patent/CA2668608A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002668608A 2006-11-08 2007-11-08 Methods for using aldhbr cells to supplement stem cell transplantation Abandoned CA2668608A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85754106P 2006-11-08 2006-11-08
US60/857,541 2006-11-08
PCT/US2007/084022 WO2008067126A2 (en) 2006-11-08 2007-11-08 Methods for using aldhbr cells to supplement stem cell transplantation

Publications (1)

Publication Number Publication Date
CA2668608A1 true CA2668608A1 (en) 2008-06-05

Family

ID=39330911

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002668608A Abandoned CA2668608A1 (en) 2006-11-08 2007-11-08 Methods for using aldhbr cells to supplement stem cell transplantation

Country Status (5)

Country Link
US (1) US20100129329A1 (https=)
EP (1) EP2089041A2 (https=)
JP (1) JP2010509360A (https=)
CA (1) CA2668608A1 (https=)
WO (1) WO2008067126A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210395835A1 (en) * 2020-06-19 2021-12-23 Caredx, Inc. Methods for monitoring allogeneic cells

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020004811A (es) * 2017-11-15 2020-10-07 Weird Science Llc Métodos y composiciones de reconstrucción no mieloablativa de médula ósea.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112969A (en) * 1994-03-17 2001-05-20 Baxter Int Pharmaceutical compositions for the treatment of cancer comprising allogenic lymphocytes or their combination with a t-cell activator
US20020159984A1 (en) * 1999-11-12 2002-10-31 Quality Biological, Inc. Cultivation of cells for long term engraftment
US7863043B2 (en) * 2004-02-11 2011-01-04 Aldagen, Inc. Stem cell populations and methods of use
WO2005107807A2 (en) * 2004-05-06 2005-11-17 University Of South Florida Cerebral intraventricular transplantation as method of treating amyotrophic lateral sclerosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210395835A1 (en) * 2020-06-19 2021-12-23 Caredx, Inc. Methods for monitoring allogeneic cells

Also Published As

Publication number Publication date
US20100129329A1 (en) 2010-05-27
WO2008067126A3 (en) 2008-10-02
JP2010509360A (ja) 2010-03-25
WO2008067126A2 (en) 2008-06-05
EP2089041A2 (en) 2009-08-19

Similar Documents

Publication Publication Date Title
US11041144B2 (en) Cell culture method
AU2018346818B2 (en) Expansion and use of expanded NK cell fractions
CA2760099A1 (en) Methods for selecting expanded stem cell populations
CN113853204A (zh) 适用于移植组合疗法的扩增nk细胞组分的扩增及其用途
JP7295810B2 (ja) 移植に適した臍帯細胞画分の選択と使用
US20100129329A1 (en) METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
US20100111905A1 (en) Methods for improved engraftment following stem cell transplantation
JP4106488B2 (ja) 同種移植片に対する免疫寛容の誘導および／または白血病処置のための、幹細胞およびｃｄ６枯渇幹細胞の使用
Sahdev et al. Hematopoietic stem cell transplantation
EP4676498A2 (en) Compositions and systems for combinatorial therapies containing fucosylated stem cells and hematopoietic enhancers and/or immunotherapeutics
Potter et al. Bone marrow and stem cell transplantation
HK40005831A (zh) 扩增自然杀手细胞部份的扩增方法及用途
Hale Perspective on the role of haploidentical transplantation in the management of hematologic malignancies: why do it?
Dunbar et al. Amendment to Clinical Research Project Project 90-C-195
Chandrinou et al. Publication only EBMT 2006
HK40027088B (zh) 适合用於移植的脐带血细胞部分的选择方法以及用途
HK40027088A (en) Selection and use of umbilical cord cell fractions suitable for transplantation
HK1228953B (en) Cell culture method
HK1228953A1 (en) Cell culture method
NZ627272B2 (en) A combination therapy for a stable and long term engraftment

Legal Events

Date Code Title Description
FZDE Discontinued